期刊文献+

2008至2012年美国国立综合癌症网络结直肠癌临床实践指南变化历程解读 被引量:27

The changes of clinical practice guidelines for colorectal cancer in the 2008-2012 National Comprehensive Cancer Network
原文传递
导出
摘要 美国国立综合癌症网络(National Comprehensive Cancer Network,NCCN)指南对于规范结直肠癌的诊治具有重要意义,其内容每年均要进行更新,关注这些变化往往意味关注肠癌研究领域的热点、难点抑或疑点。为此,本文回顾2008至2012年指南更新的重点,回首肠癌诊治进步的点滴历程,希望能发现些许启迪,以飨同道。 It is significant that National Comprehensive Cancer Network (NCCN) Guidelines for specification of colorectal cancer diagnosis and treatment. The contents is updated every year, which means the hot, difficulty or doubt spots of the field of cancer research. This paper reviews the focus of the 2008-2012 Guide updates,looking back at the stories of colorectal cancer diagnosis and treatment progress, hoping to find a little inspiration.
作者 王锡山
出处 《中华结直肠疾病电子杂志》 2012年第1期6-11,共6页 Chinese Journal of Colorectal Diseases(Electronic Edition)
关键词 结直肠肿瘤 美国国立综合癌症网络 Colorectal neoplasms National Comprehensive Cancer Network
  • 相关文献

参考文献14

  • 1Lopez-Kostner F,Lavery IC,Hool GR. Total mesorectal excision is not necessary for cancers of the upper rectum[J].Surgery,1998,(04):612-617.
  • 2Clinical Outcomes of Surgical Therapy Study Croup. A comparison of laparoseopically assisted and open colectomy forcolon cancer[J].New England Journal of Medicine,2004,(20):2050-2059.
  • 3Carden OJ,Rees M,Poston CJ. Guidelines for resectionof colorectal cancer liver metastases[J].Cut,2006,(Suppl3):Sl-S8.
  • 4Charnsangavej C,Clary B,Fong M. Selection of patients for resection of hepatic colorectal metastases:expert consensus statement[J].Annals of Surgical Oncology,2006,(10):1261-1268.
  • 5Roh MS,Colangelo LH,O 'Connell MJ. Preoperative multimodality therapy improves disease-free survival in patients wich carcinoma of the rectum:NSABP R-03[J].Journal of Clinical Oncology,2009,(31):5124-5130.
  • 6Gunderson LL,Jessup JM,Sargent DJ. Revised TN categorization for colon cancer based on national survival outcomes data[J].Journal of Clinical Oncology,2010,(02):264-271.
  • 7Sargent DJ,MarsoniS,Thibodeau SN. Defectivemismatch repair as a predictive marker for lack of efficacy of fluorouracilbased adjuvant therapy in colon cancer[J].Journal of Clinical Oncology,2010,(20):3219-3226.
  • 8Nordlinger B,Sorbye H,Collette L. Final results of the EORTC Intergroup randomized phase Ⅲ study 40983[EPOC]evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases[J].Journal of Clinical Oncology,2007,((18) suppl):LBA5.
  • 9Ychou M,Hohenberger W,Thezenas S. A randomizedphase Ⅲ study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resectionof liver metastases from colorectal cancer[J].Annals of Oncology,2009,(12):1964-1970.
  • 10Chung KY,Shia J,Keme ny NE. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growch factor receptor byimmunohistochemistry[J].Journal of Clinical Oncology,2005,(09):1803-1810.

同被引文献248

引证文献27

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部